Company / R&D Expense
Inspire Medical Systems, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$103.2M
FY2025
5-year range
$26.1M / $116.5M
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
#54 of 110
Health Care
What the data says
At $103M, Inspire Medical Systems, Inc.'s r&d expense ranks #54 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $6M in FY2017 to $117M in FY2023.
Based on SEC 10-K filings.
$103M in FY2025 with a 5-year CAGR of +31.6%.
Declined from $117M to $103M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +58.1%
- 5-Year CAGR
- +31.6%
- 10-Year CAGR
- -
Sector benchmark
#54 of 110 in Health CareTop 49% of 110This company $103.2M Sector average $298.2M
▼
-65.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +31.6%, indicating consistent growth.
- In FY2025, r&d expense decreased 9.6% year-over-year.
- Ranks #54 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $103.2M | -9.6% |
| FY2024 | $114.1M | -2.1% |
| FY2023 | $116.5M | +346.6% |
| FY2022 | $26.1M | -30.1% |
| FY2021 | $37.4M | +43.1% |
| FY2020 | $26.1M | +103.2% |
| FY2019 | $12.8M | +73.8% |
| FY2018 | $7.4M | +19.3% |
| FY2017 | $6.2M | -12.6% |
| FY2016 | $7.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026